Cited by 339Bone Tissue Engineering MaterialsTissue Engineering and Regenerative MedicineBone fractures and treatments

In vivo engineering of organs: The bone bioreactor

Open access
Stevens, Molly M., Marini, Robert P., Schaefer, Dirk, Aronson, Joshua, Langer, Robert, Shastri, V. Prasad·2005·Proceedings of the National Academy of Sciences

Abstract

Treatment of large defects requires the harvest of fresh living bone from the iliac crest. Harvest of this limited supply of bone is accompanied by extreme pain and morbidity. This has prompted the exploration of other alternatives to generate new bone using traditional principles of tissue engineering, wherein harvested cells are combined with porous scaffolds and stimulated with exogenous mitogens and morphogens in vitro and/or in vivo. We now show that large volumes of bone can be engineered in a predictable manner, without the need for cell transplantation and growth factor administration. The crux of the approach lies in the deliberate creation and manipulation of an artificial space (bioreactor) between the tibia and the periosteum, a mesenchymal layer rich in pluripotent cells, in such a way that the body's healing mechanism is leveraged in the engineering of neotissue. Using the "in vivo bioreactor" in New Zealand White rabbits, we have engineered bone that is biomechanically identical to native bone. The neobone formation followed predominantly an intramembraneous path, with woven bone matrix subsequently maturing into fully mineralized compact bone exhibiting all of the histological markers and mechanical properties of native bone. We harvested the bone after 6 weeks and transplanted it into contralateral tibial defects, resulting in complete integration after 6 weeks with no apparent morbidity at the donor site. Furthermore, in a proof-of-principle study, we have shown that by inhibiting angiogenesis and promoting a more hypoxic environment within the "in vivo bioreactor space," cartilage formation can be exclusively promoted.

Integrity signals

Registry

Crossref · 10.1073/pnas.0504705102

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Stevens, M. M., Marini, R. P., Schaefer, D., Aronson, J., Langer, R., & Shastri, V. P.
Affiliations
  • University of Basel (CH)
  • Department of Chemical Engineering, Massachusetts Institute of Technology, 45 Carleton Street, E25-342, Cambridge, MA 02139; Department of Materials, Imperial College London, Prince Consort Road, London SW7 2AZ, United Kingdom; Division of Comparative Medicine, Massachusetts Institute of Technology, 45 Carleton Street, E25-021, Cambridge, MA 02139; Department of Surgery, University of Basel, Spitalstrasse 21, 4031 Basel, Switzerland; and Department of Biomedical Engineering, Vanderbilt University,...
Venue
Proceedings of the National Academy of Sciences
Published
2005-07-29
Volume
102
Issue
32
Pages
11450-11455
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2151420872
Cited by
339
References
43
Citations by year
2026: 3 · 2025: 6 · 2024: 16 · 2023: 11 · 2022: 12 · 2021: 15 · 2020: 15 · 2019: 11 · 2018: 13 · 2017: 20 · 2016: 21 · 2015: 14 · 2014: 10 · 2013: 24 · 2012: 28
FWCI
11.60
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Physical Sciences › Engineering › Biomedical Engineering › Bone Tissue Engineering Materials
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
  • Health Sciences › Medicine › Epidemiology › Bone fractures and treatments
Keywords
bone tissue engineering, in vivo bioreactor, bone defect repair, periosteum, intramembranous ossification, woven bone, bone grafting, angiogenesis inhibition, hypoxia, chondrogenesis, rabbit model
MeSH terms
Alginates, Animals, Hexuronic Acids, Histological Techniques, Hyaluronic Acid, Organ Culture Techniques, Periosteum, Rabbits, Radiography, Tibia, Bone Transplantation, Bioreactors, Glucuronic Acid, Tissue Engineering

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review